Dov Elefant
CIK 1326487 · View on SEC EDGAR ↗
First SEC filing: Jan. 2, 2015 · Latest: Jan. 2, 2015
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 7, 2026 | FEMY | P | 15,625 | $3.20 | $50,000 | 15,625 Direct | — | Acquired | -19.5% (price as of 2026-08-20) |
| Dec. 28, 2020 | CLRB | P | 7,407 | $1.35 | $9,999 | 11,755 Direct | +170.35% | Acquired | -99.4% (price as of 2026-08-20) |
| June 5, 2020 | CLRB | P | 2,174 | $0.01 | $22 | 2,174 Direct | — | Acquired | -12.7% (price as of 2026-08-20) |
| June 5, 2020 | CLRB | P | 4,348 | $1.14 | $4,957 | 4,348 Direct | — | Acquired | -99.2% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 7, 2026 | FEMY | Common Stock Purchase Warrant | Common stock, par value $0.001 per share | — | Aug. 10, 2029 | 15,625 | Acquired |
| Aug. 7, 2026 | FEMY | Common Stock Purchase Warrant (Milestone) | Common stock, par value $0.001 per share | — | — | 15,625 | Acquired |
| March 19, 2026 | FEMY | Series D-1 Warrants | Common stock, par value $0.001 per share | — | March 19, 2036 | 34,122 | Acquired |
| Feb. 19, 2026 | FEMY | Restricted Stock Units | Common Stock (169,000) | — | — | 169,000 | Acquired |
| Feb. 19, 2026 | FEMY | Restricted Stock Units | Common Stock (173,000) | — | — | 173,000 | Acquired |
| Nov. 7, 2025 | FEMY | Series C-1 Warrants | Common stock, par value $0.001 per share | — | Nov. 7, 2035 | 34,122 | Acquired |
| Nov. 7, 2025 | FEMY | Series B-1 Warrants | Common stock, par value $0.001 per share | — | Nov. 7, 2035 | 34,122 | Acquired |
| Nov. 7, 2025 | FEMY | Series A-1 Warrants | Common stock, par value $0.001 per share | — | Nov. 7, 2035 | 34,122 | Acquired |
| Nov. 7, 2025 | FEMY | Senior Secured Convertible Notes | Common stock, par value $0.001 per share | — | Nov. 7, 2035 | — | Acquired |
| Aug. 27, 2025 | FEMY | Common Warrants (right to buy) | Common Stock (38,828) | $0.52 | Aug. 27, 2030 | 38,828 | Acquired |
| Jan. 28, 2025 | FEMY | Stock Option (Right to Buy) | Common Stock (114,300) | $1.05 | Jan. 28, 2035 | 114,300 | Acquired |
| Jan. 28, 2025 | FEMY | Stock Option (Right to Buy) | Common Stock (72,045) | $1.05 | Jan. 28, 2035 | 72,045 | Acquired |
| Feb. 1, 2024 | FEMY | Stock Option (Right to Buy) | Common Stock (84,000) | $0.80 | Feb. 1, 2034 | 84,000 | Acquired |
| July 3, 2023 | FEMY | Stock Option (Right to Buy) | Common Stock (204,700) | $0.49 | July 3, 2033 | 204,700 | Acquired |
| July 3, 2023 | FEMY | Stock Option (Right to Buy) | Common Stock (105,200) | $0.49 | July 3, 2033 | 105,200 | Acquired |
| Feb. 28, 2022 | FEMY | Stock Option (Right to Buy) | Common Stock (100,000) | $2.97 | Feb. 28, 2032 | 100,000 | Acquired |
| Jan. 25, 2022 | CLRB | Stock option (right to buy) | Common Stock (422,000) | $0.55 | Jan. 25, 2032 | 422,000 | Acquired |
| March 4, 2021 | CLRB | Stock option (right to buy) | Common Stock (430,000) | $1.74 | March 4, 2031 | 430,000 | Acquired |
| June 5, 2020 | CLRB | Series H Warrants | Common Stock (2,174) | $1.21 | June 5, 2025 | 2,174 | Acquired |
| Feb. 3, 2020 | CLRB | Stock Option (right to buy) | Common Stock (10,000) | $2.71 | Feb. 3, 2030 | 10,000 | Acquired |
| Sept. 10, 2019 | CLRB | Stock Option (right to buy) | Common Stock (90,000) | $2.32 | Sept. 10, 2029 | 90,000 | Acquired |
| Sept. 21, 2015 | AKTX | Options to Purchase Ordinary Shares | Ordinary Shares (4,067,963) | $0.32 | Sept. 21, 2025 | 4,067,963 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 2, 2015 | AKTX | Options to Purchase Ordinary Shares→ Ordinary Shares (40,000) | 40,000 | Direct |
| Jan. 2, 2015 | AKTX | Options to Purchase Ordinary Shares→ Ordinary Shares (100,000) | 100,000 | Direct |
| Jan. 2, 2015 | AKTX | Options to Purchase Ordinary Shares→ Ordinary Shares (40,000) | 40,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $356,895 | — | — | $395,600 | $85,655 | — | — | $838,150 |
| 2020 | $324,450 | $126,536 | — | $20,874 | — | — | — | $471,860 |
| 2019 | $97,500 | $57,788 | — | $157,149 | — | — | — | $312,437 |
FEMY
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $432,600 | $97,335 | — | — | — | — | $64,429 | $743,252 |
| 2024 | $432,600 | $40,067 | — | — | — | — | $76,137 | $605,836 |
| 2023 | $420,000 | $151,200 | — | — | — | — | $23,940 | $716,224 |
AKTX
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2015 | $200,000 | $37,500 | — | $857,879 | — | — | — | $1,095,379 |
| 2014 | $200,000 | — | — | $20,188 | — | — | — | $220,188 |
| 2013 | $163,472 | $50,000 | — | $25,120 | — | — | — | $238,592 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.